Finally, as mentioned above, if it is confirmed that MRV produces uncapped RNAs with pGp 5′ ends late during infection, how well are such ends recognized by RIG-I and would pGp 5′ ends provide an advantage or disadvantage for the virus with respect to innate immune activation? This evidence concerns the gene RIGI and infection.